Breakfast Meeting: Compliance Maturity in Danish Life Science
Friday, June 9: 8:30 - 10:30
Epista Life Science, Slotsmarken 17, 2nd Floor, 2970 Hørsholm
Register here! (Event is free for industry practitioners)
Danish Life Science companies are asking serious questions about their compliance maturity:
- Are we over-spending on time and resources, hampering efficiency and our bottom line?
- Are we underspending, running the risk of out-of-control compliance?
A new study presents a snapshot of compliance maturity in the Danish Life Science industry, and sheds light on important industry challenges and trends. Where does your company fall on the compliance maturity scale? Is your compliance optimal?
Join this breakfast meeting to learn the results & insights from the study: 2017 Benchmark of Compliance Maturity in Danish Life Science. And get insight and inspiration to assess your own compliance maturity - and ultimately make your efforts more transparent, predictable and efficient.
What is compliance maturity and why does it matter?
We'll address the dimensions that go into compliance maturity - "How much compliance are you actually doing?" - versus - "What are your quality objectives?". At the immature end of the scale lies Asymmetric Compliance with sporadic processes and short term focus. On the mature end of the scale lies Advancing Compliance where quality targets are measured and quality controls are integrated in processes and systems. And there are several steps between. When you know where you lie on the scale, you can identify concrete tasks to tune your compliance efforts to the optimal level.
At Epista, our mission is to continuously improve regulatory compliance - both for our clients and the Life Science industry. This event is one of the ways we achieve that goal. We sincerely hope to see you at this important event, where there will also be plenty of time to network with your industry peers.
Questions? Write email@example.com.
Note: This is an open invitation and a free event for industry practitioners. If you fall into this category, please share with colleagues and other relevant people in your network. This event is not open to consultants or vendors.
Registration and Networking Breakfast
Welcome and Overview
Explanation of Model, Hypothesis, and Survey
Results and Conclusions
The CIRC Model
Klavs Esbjerg, CEO and Founder, Epista Life Science
Lars Moltke Hansen, Senior Consultant, Epista Life Science
Malene Mayntzhusen Christensen, Senior Consultant, Epista Life Science
Coffee and Networking